Wells Fargo’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,270
| Closed | -$2K | – | 6484 |
|
|
2019
Q1 | $2K | Hold |
2,270
| – | – | ﹤0.01% | 5731 |
|
|
2018
Q4 | $2K | Sell |
2,270
-26,374
| -92% | -$23.2K | ﹤0.01% | 5769 |
|
|
2018
Q3 | $61K | Sell |
28,644
-755
| -3% | -$1.61K | ﹤0.01% | 5259 |
|
|
2018
Q2 | $68K | Buy |
29,399
+1,750
| +6% | +$4.05K | ﹤0.01% | 5259 |
|
|
2018
Q1 | $88K | Sell |
27,649
-1,037
| -4% | -$3.3K | ﹤0.01% | 5115 |
|
|
2017
Q4 | $118K | Buy |
28,686
+24,196
| +539% | +$99.5K | ﹤0.01% | 5029 |
|
|
2017
Q3 | $20K | Sell |
4,490
-6,084
| -58% | -$27.1K | ﹤0.01% | 5387 |
|
|
2017
Q2 | $35K | Sell |
10,574
-37,903
| -78% | -$125K | ﹤0.01% | 5211 |
|
|
2017
Q1 | $446K | Buy |
48,477
+28,977
| +149% | +$267K | ﹤0.01% | 4214 |
|
|
2016
Q4 | $150K | Sell |
19,500
-30,036
| -61% | -$231K | ﹤0.01% | 4730 |
|
|
2016
Q3 | $566K | Buy |
49,536
+36,910
| +292% | +$422K | ﹤0.01% | 3779 |
|
|
2016
Q2 | $155K | Sell |
12,626
-2,629
| -17% | -$32.3K | ﹤0.01% | 4400 |
|
|
2016
Q1 | $155K | Sell |
15,255
-383,239
| -96% | -$3.89M | ﹤0.01% | 4420 |
|
|
2015
Q4 | $8.98M | Buy |
398,494
+70,942
| +22% | +$1.6M | ﹤0.01% | 1906 |
|
|
2015
Q3 | $5.44M | Buy |
327,552
+308,890
| +1,655% | +$5.13M | ﹤0.01% | 2251 |
|
|
2015
Q2 | $420K | Buy |
18,662
+17,975
| +2,616% | +$405K | ﹤0.01% | 4100 |
|
|
2015
Q1 | $18K | Hold |
687
| – | – | ﹤0.01% | 5231 |
|
|
2014
Q4 | $15K | Buy |
687
+103
| +18% | +$2.25K | ﹤0.01% | 5270 |
|
|
2014
Q3 | $11K | Sell |
584
-316
| -35% | -$5.95K | ﹤0.01% | 5389 |
|
|
2014
Q2 | $21K | Buy |
900
+446
| +98% | +$10.4K | ﹤0.01% | 5220 |
|
|
2014
Q1 | $15K | Buy |
454
+150
| +49% | +$4.96K | ﹤0.01% | 5161 |
|
|
2013
Q4 | $9K | Sell |
304
-6,198
| -95% | -$183K | ﹤0.01% | 5103 |
|
|
2013
Q3 | $100K | Buy |
+6,502
| New | +$100K | ﹤0.01% | 4424 |
|